<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-167479</identifier>
<setSpec>1131-3587</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Prognostic implications of peripheral arterial disease for ischemic heart disease</dc:title>
<dc:description xml:lang="en">Atherosclerosis is a progressive pathophysiologic process that can simultaneously affect a number of different vascular beds and that can be caused by a range of factors such as diabetes mellitus, smoking, hypertension and dyslipidemia. Consequently, coronary artery disease and peripheral arterial disease (PAD) frequently coexist. Recently published data suggest that the presence of PAD in a patient with coronary artery disease implies a poorer prognosis than would be expected from classical risk factors alone. These findings indicate that PAD is an independent risk factor in different subgroups of patients with ischemic heart disease. Consequently, early diagnosis of PAD in these patients by measuring the ankle-brachial index would appear to be an essential step in identifying those at a high risk and in bringing about an increase in the use of currently available preventive and therapeutic measures in these patients (AU)</dc:description>
<dc:creator>Morillas Blasco, Pedro</dc:creator>
<dc:creator>Castillo Castillo, Jesús</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La aterosclerosis es un proceso fisiopatológico progresivo que puede afectar simultáneamente a múltiples territorios vasculares y tiene origen en diversos factores como la diabetes mellitus, el tabaquismo, la hipertensión arterial o la dislipemia. Consecuentemente, la coexistencia de enfermedad arterial coronaria y enfermedad arterial periférica (EAP) es frecuente. Recientemente se han publicado datos que indican que la EAP en el paciente con enfermedad coronaria podría implicar un pronóstico peor que el meramente establecido por los factores de riesgo clásicos. Éstos señalan a la EAP como un marcador de riesgo independiente en los distintos subgrupos de pacientes con cardiopatía isquémica. Por lo tanto, la criba de EAP mediante el índice tobillo-brazo en esta población parece un paso obligado para detectar a pacientes en mayor riesgo e intensificar en ellos las medidas preventivas y terapéuticas de que disponemos (AU)</dc:description>
<dc:source>Rev. esp. cardiol. Supl. (Ed. impresa);9(supl.D): 24d-30d, 2009. graf, tab</dc:source>
<dc:identifier>ibc-167479</dc:identifier>
<dc:title xml:lang="es">Valor pronóstico de la enfermedad arterial periférica en la cardiopatía isquémica</dc:title>
<dc:subject>^d53992^s22016</dc:subject>
<dc:subject>^d3343^s22012</dc:subject>
<dc:subject>^d11812</dc:subject>
<dc:subject>^d52613^s22012</dc:subject>
<dc:subject>^d30650^s22016</dc:subject>
<dc:subject>^d30650^s22032</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30650^s22012</dc:subject>
<dc:subject>^d53992^s22032</dc:subject>
<dc:subject>^d3343^s22080</dc:subject>
<dc:type>article</dc:type>
<dc:date>200900</dc:date>
</metadata>
</record>
</ibecs-document>
